Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Message From the Editors to Our Reviewers.

Neurology·2026
Same author

Substance Use and Toxicology Screening in Young Adults With Acute Ischemic Stroke.

The Neurohospitalist·2026
Same author

Gene Expression Profiles at Early vs Late Stages After Cervical Artery Dissection.

Neurology. Genetics·2026
Same author

Associated Factors and Outcomes of Patients With Intracerebral Hemorrhage After Permanent Cerebrospinal Fluid Shunt Placement.

Neurosurgery·2026
Same author

Diversity in genetic risk of recurrent stroke: a genome-wide association study meta-analysis.

Frontiers in stroke·2026
Same author

The importance and challenge of comparing stroke care, utilization and outcomes in Medicare Advantage and Fee-for-Service Medicare: a narrative review and vision for the future.

Journal of comparative effectiveness research·2026

Related Experiment Video

Updated: Jul 11, 2026

Transient Middle Cerebral Artery Occlusion Model of Stroke
05:32

Transient Middle Cerebral Artery Occlusion Model of Stroke

Published on: August 11, 2023

Sex differences in stroke evaluations in the Ischemic Stroke Genetics Study.

Thabele M Leslie-Mazwi1, Thomas G Brott, Robert D Brown

  • 1Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|September 12, 2007
PubMed
Summary

This study found no significant sex differences in diagnostic test utilization for ischemic stroke patients in a specialized stroke center. Tertiary stroke centers may help reduce evaluation biases in stroke diagnosis.

Related Experiment Videos

Last Updated: Jul 11, 2026

Transient Middle Cerebral Artery Occlusion Model of Stroke
05:32

Transient Middle Cerebral Artery Occlusion Model of Stroke

Published on: August 11, 2023

Area of Science:

  • Neurology
  • Medical Diagnostics
  • Epidemiology

Background:

  • Previous studies indicate sex disparities in the evaluation of patients experiencing ischemic stroke.
  • These disparities may impact the accuracy of diagnosing different ischemic stroke subtypes.
  • This research specifically examined sex differences within the Ischemic Stroke Genetics Study (ISGS).

Purpose of the Study:

  • To investigate potential sex-based differences in diagnostic test utilization among ischemic stroke patients.
  • To determine if tertiary stroke centers mitigate sex bias in stroke evaluation.

Main Methods:

  • The Ischemic Stroke Genetics Study (ISGS) enrolled 505 patients (45% women) with first-ever ischemic stroke.
  • This prospective, case-control genetic association study was conducted at 5 US tertiary stroke centers.
  • Diagnostic tests performed during routine medical care were systematically recorded for all participants.

Main Results:

  • No significant sex differences were observed in the performance rates of key diagnostic tests, including brain CT, MRI, ECG, echocardiography, cervical arterial imaging, and intracranial vascular imaging.
  • Women were older at the time of stroke onset compared to men (66.6 vs. 61.9 years, P = .001).
  • While not statistically significant, women showed slightly higher rates of echocardiography and intracranial vascular imaging.

Conclusions:

  • The findings suggest that the utilization of major diagnostic tests for ischemic stroke is comparable between men and women within the ISGS cohort.
  • Specialized tertiary stroke centers appear to minimize sex-based biases in diagnostic evaluations for stroke patients.
  • This indicates a potential model for equitable stroke care and diagnosis.